In 2013, mutations in the calreticulin gene (CALR) in JAK2 V617F- and MPL-negative patients with ET were identified [17,18] with the diagnostic value of CALR mutations in diagnosing ET confirmed in 2016 [19]. The gene discussed is JAK2; the disease is essential thrombocythemia.